PI3K/Akt抑制剂联合西妥昔单抗对人肺癌细胞的体外抑制作用(4)
 |
| 第1页 |
参见附件。
[4] Scrima M，De Marco C，Fabiani F，et al. Signaling networks associated with AKT activation in non—small cell lung cancer(NSCLC)：new insights on the role of phosphatydil—inositol—3 kinase[J]. PLoS One，2012，7(2)：e30427.
[5] Wu D，Tao J，Xu B，et al. Phosphatidylinositol 3—kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells[J]. Urol Int，2011，87(1)：105—113.
[6] Jiang H，Fan D，Zhou G，et al. Phosphatidylinositol 3—kinase inhibitor(LY294002)induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo[J]. J Exp Clin Cancer Res，2010，22：29—34.
[7] Chou TC，Talalay P. Quantitative analysis of dose—effect relationships：the combined effects of multiple drugs or enzyme inhibition[J]. Adv Enzyme Regul，1984，22：27—55.
[8] Massion PP，Taflan PM，Shyr Y，et al. Early involvement of the phosphatidylinositol 3—kinase/Akt pathway in lung cancer progression[J]. Am J Respir Crit Care Med，2004，170(10)：1088—1094.
[9] Datta K，Bellacosa A，Chan TO，et al. Akt is a direct target of the phosphatidylinositol 3—kinase. Activation by growth factors，v—src and vHaras，in Sf9 and mammalian cells[J]. J Biol Chem，1996，271(48)：30835—30839.
[10] Tang JM，He QY，Guo RX，et al. Phosphorylated Akt overexpression and loss of PTEN expression in non—small cell lung cancer confers poor prognosis[J]. Lung Cancer， 2006，51(2)：181—191.
[11] Brunet A，Bonni A，Zigmond MJ，et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor[J]. Cell，1999，96(6)： 857—681.
[12] Mallawaaratchy DM ......
您现在查看是摘要介绍页，详见PDF附件(4155kb)。